Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Daniel Berson

Anesthesiology Austin, TX Doctor of Osteopathy

NPI 1447224415 CMS profile 1229800

2304 Hancock Dr Ste 4, Austin, TX 78756

Open in the dashboard

General payments

$57,770

161 records reported · program years 2019–2025

Research payments

$142,670

Paid to them · 10 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$37,800 paid to institutions, not to them · program years 2021–2025

Through program year 2025, Daniel Berson of Austin, TX is reported in the CMS Open Payments database as having received $57,770 across 161 general payments and $142,670 in research payments paid to them. Separately, studies naming them as principal investigator received $37,800 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Anesthesiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

11 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $19,014 48
2024 General $11,560 26
2024 Research $3,670 3
2023 General $1,876 18
2023 Research $3,600 2
2022 General $23,595 40
2021 General $754 11
2020 General $75 4
2020 Research $135,000 3
2019 General $896 14
2019 Research $400 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Daniel Berson
  • Anesthesiology median
  • Middle half of Anesthesiology
  • National median

In program year 2025, general payments to Daniel Berson were reported at $19,014. Among 18,548 Anesthesiology profiles paid that year, the median was $58 and the middle half received between $26 and $153.

Show as a table
Year Daniel Berson Anesthesiology median Middle half National median
2019 $896 $72 $23–$151 $163
2020 $75 $36 $17–$120 $114
2021 $754 $49 $21–$135 $132
2022 $23,595 $52 $22–$144 $149
2023 $1,876 $53 $23–$143 $160
2024 $11,560 $55 $25–$150 $164
2025 $19,014 $58 $26–$153 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Haemonetics Corporation $25,689 34 payments
  2. Philips Electronics North America Corporation $23,137 33 payments
  3. Edwards Lifesciences Corporation $2,875 27 payments
  4. Abiomed $1,895 12 payments
  5. Abbott Laboratories $1,627 17 payments
  6. Ancora Heart, Inc. $857 4 payments
  7. Baxter Healthcare $635 8 payments
  8. Medtronic Vascular, Inc. $208 3 payments
  9. Pacira Pharmaceuticals Incorporated $137 2 payments
  10. Covidien LP $130 1 payment
  11. Other $581 20 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $17,152 31 payments
  2. Honoraria $14,316 5 payments
  3. Consulting Fee $13,464 3 payments
  4. Food and Beverage $7,703 119 payments
  5. Acquisitions $2,765 1 payment
  6. Education $2,370 2 payments
Products named General payments · program years 2019–2025
  1. TEG6s HEMOSTASIS SYSTEM $25,387 30 payments
  2. TEG Manager $23,454 6 payments
  3. (1658) Educ Ultrasound $10,179 21 payments
  4. (1658) Clin Educ US $3,500 1 payment
  5. (1658) Clinical Educ Ultrasound $3,500 1 payment
  6. (9210) Undivided $2,765 1 payment
  7. Impella $1,847 11 payments
  8. (0054) Support function $1,185 1 payment
  9. (5044) MCOT $1,185 1 payment
  10. TRICLIP $1,035 11 payments
  11. Other $5,180 60 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Philips Electronics North America Corporation $142,670 10 payments

Billing to Medicare

Part B · data year 2024 · 30 billing codes

Paid by Medicare

$52,963

Medicare's payments for the services billed

Medicare patients

122

Average age 76

Services billed

396

50 women, 72 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 75%
Atrial fibrillation 56%
Heart failure 54%
Arthritis 52%
Chronic kidney disease 42%
Diabetes 41%
COPD 26%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

171 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Anesthesiology in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record